Adaptation of the COVASIM model to incorporate non-pharmaceutical interventions: Application to the Dominican Republic during the second wave of COVID-19

[1] Alimohamadi, Y., Sepandi, M., Taghdir, M., & Hosamirudsari, H. (2020). Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J. Prev. Med. Hyg., 61(3), E304. Search in Google Scholar

[2] Sáez, C., Romero, N., Conejero, J. A., & García-Gómez, J. M. (2021). Potential limitations in COVID-19 machine learning due to data source variability: A case study in the ncov2019 dataset. J. Am. Med. Inform. Assoc., 28(2), 360–364. Search in Google Scholar

[3] Zhou, L., Romero-García, N., Martínez-Miranda, J., Conejero, J. A., et al. (2022). Subphenotyping of Mexican patients with COVID-19 at preadmission to anticipate severity stratification: age-sex unbiased meta-clustering technique. JMIR Public Health Surveill., 8(3), e30032. Search in Google Scholar

[4] Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., et al. (2020). Remdesivir for the treatment of COVID-19 preliminary report. N. Engl. J. Med., 383(19), 1813–1836. Search in Google Scholar

[5] Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020). COVID-19: Immunology and treatment options. Clin. Immunol., 215, 108448. Search in Google Scholar

[6] Gysia, D. M., do Vallea, I., Zitnikd, M., Amelib, A., et al. (2021). Network medicine framework for identifying drug repurposing opportunities for COVID-19. Proc. Natl. Acad. Sci. U.S.A., 118(19), e2025581118. Search in Google Scholar

[7] Cunningham, A. C., Goh, H. P., & Koh, D. (2020). Treatment of COVID-19: old tricks for new challenges. Crit. Care, 24, 1–2. Search in Google Scholar

[8] Bertozzi, A. L., Franco, E., Mohler, G., Short, M. B., & Sledge, D. (2020). The challenges of modeling and forecasting the spread of COVID-19. Proc. Natl. Acad. Sci. U.S.A., 117(29), 16732–16738. Search in Google Scholar

[9] Estrada, E. (2020). COVID-19 and SARS-CoV-2. Modeling the present, looking at the future. Phys. Rep., 869, 1–51. Search in Google Scholar

[10] Arenas, A., Cota, W., Gómez-Gardeñes, J., Gómez, S., et al. (2020). Modeling the spatiotemporal epidemic spreading of COVID-19 and the impact of mobility and social distancing interventions. Phys. Rev. X, 10(4), 041055. Search in Google Scholar

[11] Muñoz-Fernández, G. A., Seoane, J. M., & Seoane-Sepúlveda, J. B. (2021). A SIR-type model describing the successive waves of COVID-19. Chaos, Solitons & Fractals, 144, 110682. Search in Google Scholar

[12] Angeli, M., Neofotistos, G., Mattheakis, M., & Kaxiras, E. (2022). Modeling the effect of the vaccination campaign on the COVID-19 pandemic. Chaos, Solitons & Fractals, 154, 111621. Search in Google Scholar

[13] Kumar, P., Erturk, V. S., & Murillo-Arcila, M. (2021). A new fractional mathematical modelling of COVID-19 with the availability of vaccine. Results Phys., 24, 104213. Search in Google Scholar

[14] Liu, K., & Lou, Y. (2022). Optimizing COVID-19 vaccination programs during vaccine shortages: A review of mathematical models. Infect. Dis. Model. Search in Google Scholar

[15] Lozano, M. A., Garibo-i Orts, Ò., Piñol, E., Rebollo, M., et al. (2021). Open data science to fight COVID-19: Winning the 500k XPRIZE Pandemic Response Challenge. In Machine Learning and Knowledge Discovery in Databases. Applied Data Science Track: European Conference, ECML PKDD 2021, Bilbao, Spain, September 13–17, 2021, Proceedings, Part IV (pp. 384–399). Springer. Search in Google Scholar

[16] Lozano, M. A., Garibo-i Orts, Ò., Piñol, E., Rebollo, M., et al. (2022). Open data science to fight COVID-19: Winning the 500k XPRIZE Pandemic Response Challenge (extended abstract). In L. De Raedt (Ed.), Proceedings of the Thirty-First International Joint Conference on Artificial Intelligence, IJCAI-22 (pp. 5304–5308). International Joint Conferences on Artificial Intelligence Organization. Search in Google Scholar

[17] Janko, V., Resčič, N., Vodopija, A., Susič, D., et al. (2023). Optimizing non-pharmaceutical intervention strategies against COVID-19 using artificial intelligence. Front. Pub. Health, 11. Search in Google Scholar

[18] Chao, D., Halloran, M., Obenchain, V., & Longini Jr, I. (2010). FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS Comput. Biol., 6(1), e1000656. Search in Google Scholar

[19] Koo, J., Cook, A., Park, M., Sun, Y., et al. (2020). Interventions to mitigate early spread of SARSCOV-2 in Singapore: a modelling study. Lancet Infect. Dis., 20(6), 678–688. Search in Google Scholar

[20] Moreno López, J., Arregui García, B., Bentkowski, P., Bioglio, L., et al. (2021). Anatomy of digital contact tracing: Role of age, transmission setting, adoption, and case detection. Sci. Adv., 7(15), eabd8750. Search in Google Scholar

[21] Faucher, B., Assab, R., Roux, J., Levy-Bruhl, D., et al. (2022). Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19. Nat. Commun., 13(1), 1–11. Search in Google Scholar

[22] Rockett, R. J., Arnott, A., Lam, C., Sadsad, R., et al. (2020). Revealing COVID-19 transmission in Australia by SARSCOV-2 genome sequencing and agent-based modeling. Nature Med., 26(9), 139 Search in Google Scholar

[23] Howick, S., McLafferty, D., Anderson, G. H., Pravinkumar, S. J., et al. (2021). Evaluating intervention strategies in controlling coronavirus disease 2019 (COVID-19) spread in care homes: An agent-based model. Infect. Control & Hosp. Epidemiol., 42(9), 1060–1070. Search in Google Scholar

[24] Truszkowska, A., Behring, B., Hasanyan, J., Zino, L., et al. (2021). High-resolution agent-based modeling of COVID-19 spreading in a small town. Adv. Theory Simul., 4(3), 2000277. Search in Google Scholar

[25] Yin, L., Zhang, H., Li, Y., Liu, K., et al. (2021). A data-driven agent-based model that recommends nonpharmaceutical interventions to suppress coronavirus disease 2019 resurgence in megacities. J. R. Soc. Interface, 18(181), 20210112. Search in Google Scholar

[26] Hoertel, N., Blachier, M., Blanco, C., Olfson, M., et al. (2020). A stochastic agent-based model of the SARS-CoV-2 epidemic in France. Nature Med., 26(9), 1417–1421. Search in Google Scholar

[27] Romero-Brufau, S., Chopra, A., Ryu, A. J., Gel, E., et al. (2021). Public health impact of delaying second dose of BNT162b2 or mRNA-1273 COVID-19 vaccine: simulation agent-based modeling study. BMJ, 373. Search in Google Scholar

[28] Hinch, R., Probert, W. J. M., Nurtay, A., Kendall, M., et al. (2021). OpenABM - Covid19 - An agent-based model for non-pharmaceutical interventions against COVID-19 including contact tracing. PLoS Comput. Biol., 17(7), e1009146. Search in Google Scholar

[29] Kano, T., Yasui, K., Mikami, T., Asally, M., & Ishiguro, A. (2021). An agent-based model of the interrelation between the COVID-19 outbreak and economic activities. Proc. Math. Phys. Eng. Sci., 477(2245), 20200604. Search in Google Scholar

[30] Silva, P. C. L., Batista, P. V. C., Lima, H. S., Alves, M. A., et al. (2020). COVID-ABS: An agent-based model of COVID19 epidemic to simulate health and economic effects of social distancing interventions. Chaos, Solitons & Fractals, 139, 110088. Search in Google Scholar

[31] Rahman, T., Taghikhah, F., Paul, S. K., Shukla, N., & Agarwal, R. (2021). An agent-based model for supply chain recovery in the wake of the COVID-19 pandemic. Comput. Ind. Eng., 158, 107401. Search in Google Scholar

[32] Ferguson, N., Laydon, D., Nedjati Gilani, G., Imai, N., Ainslie, K., et al. (2020). Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Search in Google Scholar

[33] Chao, D. L., Oron, A. P., Srikrishna, D., & Famulare, M. (2020). Modeling layered non-pharmaceutical interventions against SARS-CoV-2 in the United States with Corvid. MedRxiv, 2020–04. Search in Google Scholar

[34] Krivorotko, O., Sosnovskaia, M., Vashchenko, I., Kerr, C., & Lesnic, D. (2022). Agent-based modeling of COVID-19 outbreaks for New York state and UK: Parameter identification algorithm. Infect. Dis. Model., 7(1), 30–44. Search in Google Scholar

[35] Kerr, C., Stuart, R., Mistry, D., Abeysuriya, R., et al. (2021). Covasim: an agent-based model of COVID-19 dynamics and interventions. PLoS Comput. Biol., 17(7), e1009149. Search in Google Scholar

[36] Hale, T., Angrist, N., Goldszmidt, R., Kira, B., et al. (2021). A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat. Hum. Behav., 5(4), 529–538. Search in Google Scholar

[37] Shen, Y., Powell, G., Ganser, I., Zheng, Q., et al. (2021). Monitoring non-pharmaceutical public health interventions during the COVID-19 pandemic. Sci. Data, 8(1), 225. Search in Google Scholar

[38] Zheng, Q., Jones, F. K., Leavitt, S. V., Ung, L., et al. (2020). HIT-COVID, a global database tracking public health interventions to COVID-19. Sci. Data, 7(1), 286. Search in Google Scholar

[39] Porcher, S. (2020). Response2covid19, a dataset of governments’ responses to COVID-19 all around the world. Sci. Data, 7(1), 423. Search in Google Scholar

[40] Cheng, C., Barceló, J., Hartnett, A. S., Kubinec, R., & Messerschmidt, L. (2020). COVID-19 government response event dataset (Coronanet v. 1.0). Nature Human Behav., 4(7), 756–768. Search in Google Scholar

[41] Elgin, C., Basbug, G., & Yalaman, A. (2020). Economic policy responses to a pandemic: Developing the COVID-19 economic stimulus index. Covid Economics, 1(3), 40–53. Search in Google Scholar

[42] Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., et al. (2021). Estimated transmissibility and impact of SARS-CoV-2 lineage b.1.1.7 in England. Science, 372(6538), eabg3055. Search in Google Scholar

[43] Miikkulainen, R., Francon, O., Meyerson, E., Qiu, X., Sargent, D., Canzani, E., & Hodjat, B. (2021). From prediction to prescription: Evolutionary optimization of nonpharmaceutical interventions in the COVID-19 pandemic. IEEE Trans. Evol. Comput, 25(2), 386–401. Search in Google Scholar

[44] Hale, T., Angrist, N., Goldszmidt, R., Kira, B., et al. (2021). COVID-19 Government Response Tracker. https://github.com/OxCGRT/covid-policy-tracker/blob/master/documentation/codebook.md Search in Google Scholar

[45] Valencia IA4COVID. (2021). XPRIZE Pandemic Response hallenge. https://github.com/malozano/valencia-ia4covid-xprize Search in Google Scholar

[46] United Nations. (2019). Population division. https://www.un.org/development/desa/pd/ Search in Google Scholar

[47] Oliver, N., Lepri, B., Sterly, H., Lambiotte, R., et al. (2020). Mobile phone data for informing public health actions across the COVID-19 pandemic life cycle. Science Adv., 6(23), eabc0764. Search in Google Scholar

[48] Hamer, D. H., White, L. F., Jenkins, H. E., Gill, C. J., et al. (2021). Control of COVID-19 transmission on an urban university campus during a second wave of the pandemic. medRxiv, pages 2021–02. Search in Google Scholar

[49] Kerr, C. C., Mistry, D., Stuart, R. M., Rosenfeld, K., et al. (2021). Controlling COVID-19 via test-trace-quarantine. Nature Comm., 12(1), 2993. Search in Google Scholar